New combo therapy offers hope for advanced colorectal cancer patients
NCT ID NCT06071052
First seen Jan 06, 2026 · Last updated Jun 17, 2026 · Updated 22 times
Summary
This study tested a three-part treatment for people with colorectal cancer that spread to the liver and stopped responding to standard therapies. The treatment combined targeted chemotherapy beads injected into the liver, chemotherapy infusion into the liver artery, and a targeted drug called regorafenib. The goal was to see if this combination could shrink tumors and extend life. 21 patients participated in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
the first affiliated hospital, Sun-Yat sen university
Guangzhou, Guangdong, 510000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.